Latest filings (excl ownership)
10-Q
2024 Q1
Quarterly report
9 May 24
EFFECT
Notice of effectiveness
6 May 24
424B3
Prospectus supplement
3 May 24
425
Business combination disclosure
4 Apr 24
10-K
2023 FY
Annual report
14 Mar 24
S-4
Registration of securities issued in business combination transactions
13 Feb 24
425
Business combination disclosure
30 Jan 24
425
Business combination disclosure
30 Jan 24
8-K
Regulation FD Disclosure
30 Jan 24
425
Business combination disclosure
30 Jan 24
8-K
AVROBIO and Tectonic Therapeutic Announce Merger
30 Jan 24
10-Q
2023 Q3
Quarterly report
9 Nov 23
RW
Registration withdrawal request
3 Nov 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
8-K
AVROBIO to Explore Strategic Alternatives
12 Jul 23
8-K/A
Cost Associated with Exit or Disposal Activities
14 Jun 23
8-K
Other Events
13 Jun 23
8-K
Termination of a Material Definitive Agreement
12 Jun 23
8-K
Departure of Directors or Certain Officers
9 Jun 23
8-K
AVROBIO Announces Agreement to Sell Cystinosis Gene Therapy Program for $87.5 Million
22 May 23
8-K
AVROBIO Announces Positive Data from Phase 1/2 Clinical Trial of
18 May 23
10-Q
2023 Q1
Quarterly report
11 May 23
8-K
AVROBIO Reports First Quarter 2023 Financial Results and Provides Business Update
11 May 23
ARS
2022 FY
Annual report to shareholders
5 May 23
DEF 14A
Definitive proxy
1 May 23
8-K
AVROBIO Announces Leadership Transition
1 May 23
S-8
Registration of securities for employees
23 Mar 23
10-K
2022 FY
Annual report
23 Mar 23
8-K
AVROBIO Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Business Update
23 Mar 23
8-K
Other Events
27 Feb 23
8-K
Regulation FD Disclosure
7 Dec 22
S-3
Shelf registration
8 Nov 22
10-Q
2022 Q3
Quarterly report
8 Nov 22
8-K
AVROBIO Reports Third Quarter 2022 Financial Results and Provides Business Update
8 Nov 22
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
7 Oct 22
8-K
AVROBIO Reports Second Quarter 2022 Financial Results and Provides Business Update
9 Aug 22
10-Q
2022 Q2
Quarterly report
9 Aug 22
Latest ownership filings
SC 13G
Newtyn Management, LLC
14 Feb 24
SC 13G/A
TANG CAPITAL PARTNERS LP
14 Feb 24
SC 13G/A
GMT CAPITAL CORP
13 Feb 24
SC 13G/A
BML Investment Partners, L.P.
7 Feb 24
4
Azadeh Golipour
5 Feb 24
4
Essra Ridha
5 Feb 24
4
Erik Ostrowski
5 Feb 24
4
Steven Avruch
5 Feb 24
SC 13G/A
Farallon Capital Partners, L.P.
24 Jan 24
SC 13G
BML Investment Partners, L.P.
24 Jul 23
144
Notice of proposed sale of securities
14 Jul 23
4
Erik Ostrowski
3 Jul 23
4
Azadeh Golipour
13 Jun 23
4
CHRISTOPHER PAIGE
8 Jun 23
4
Phillip B. Donenberg
8 Jun 23
4
Philip J. Vickers
8 Jun 23
4
Gail M Farfel
8 Jun 23
4
Bruce Booth
8 Jun 23
4
Annalisa Jenkins
8 Jun 23
4
IAN T CLARK
8 Jun 23
144
Notice of proposed sale of securities
7 Jun 23
SC 13G
TANG CAPITAL PARTNERS LP
6 Jun 23
144
Notice of proposed sale of securities
5 Jun 23
144
Notice of proposed sale of securities
25 May 23
144
Notice of proposed sale of securities
24 May 23
144
Notice of proposed sale of securities
24 May 23
144
Notice of proposed sale of securities
24 May 23
SC 13G
Farallon Capital Partners, L.P.
17 Feb 23
4
Deanna M Petersen
10 Feb 23
4
Essra Ridha
10 Feb 23
4
Erik Ostrowski
10 Feb 23
4
Azadeh Golipour
10 Feb 23
4
GEOFFREY MACKAY
10 Feb 23
4
Steven Avruch
10 Feb 23
SC 13G/A
K2 PRINCIPAL FUND, L.P.
8 Feb 23
4
GEOFFREY MACKAY
26 Jan 23
SC 13G/A
GMT CAPITAL CORP
19 Jan 23
4
GEOFFREY MACKAY
28 Dec 22
4
Essra Ridha
9 Dec 22
4
Deanna M Petersen
9 Dec 22